This depends on your individual health profile and current medications
A recently published study (ESSENCE Trial) in the New England Journal of Medicine looked at the effects of once weekly semaglutide 2.4mg versus placebo in patients with biopsy-confirmed MASH
While individual results vary, the numbers speak for themselves: Mounjaros dual-action approach gives it a distinct advantage
The Phase 2 readout already signaled that retatrutide was operating in a different category, mean weight loss in the 24% range at the highest dose, a number that until recently was the exclusive territory of bariatric surgery
By educating patients about the recommended percentages of calories from carbohydrates, proteins, and fats, nurses empower patients to make informed dietary choices that support blood glucose control, lipid management, and overall health